Treating MS after surviving PML: Discrete strategies for rescue, remission, and recovery patient 1-Reference-Cited by-同舟云学术

Treating MS after surviving PML: Discrete strategies for rescue, remission, and recovery patient 1

Published:2020-12-15 Issue:1 Volume:8 Page:e929
ISSN:2332-7812
Container-title:Neurology - Neuroimmunology Neuroinflammation
language:en
Short-container-title:Neurol Neuroimmunol Neuroinflamm

Author:

Anadani Nidhiben,Hyland Megan,Cruz Roberto Alejandro,Lisak Robert,Costello Kathleen,Major Eugene O.,Jassam Yasir,Meltzer Ethan,Varkey Thomas C.^ORCID,Parsons Matthew S.,Goodman Andrew D.,Graves Jennifer S.,Newsome Scott,Zamvil Scott S.,Frohman Elliot M.,Frohman Teresa C.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Neurology (clinical),Neurology

Reference14 articles.

1. Prosperini L , Kinkel RP , Miravalle AA , Iaffaldano P , Fantaccini S . Post-natalizumab disease reactivation in multiple sclerosis: systematic review and meta-analysis. Ther Adv Neurol Disord Epub 2019 Mar 29.

2. The thalamus and multiple sclerosis: Modern views on pathologic, imaging, and clinical aspects

3. Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy

4. PML diagnostic criteria

5. Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Escalation to Anti-CD20 Treatment for Multiple Sclerosis Following Natalizumab-Associated Progressive Multifocal Leukoencephalopathy;Neurology Clinical Practice;2024-10

2. Progressive multifocal leukoencephalopathy in the clinical practice of a neurologist. Case report;Consilium Medicum;2024-05-09

3. Chitinase-3-like 1-protein in CSF: a novel biomarker for progression in patients with multiple sclerosis;Neurological Sciences;2023-03-29

4. Recurrent Optic Neuritis and Perineuritis Followed by an Unexpected Discovery;Neurology - Neuroimmunology Neuroinflammation;2022-11-10

5. Multiple Sclerosis Followed by Neuromyelitis Optica Spectrum Disorder;Neurology - Neuroimmunology Neuroinflammation;2022-10-21